Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Funding Open access funding provided by the National Institutes of Health
Researchers believe BPC-157 may help support healing and recovery through several mechanisms
This apparently minor modification produces a substantial functional change: the N-terminal tripeptide is the primary binding domain through which IGF-1 interacts with IGFBP-3 and IGFBP-1, the two most abundant binding proteins in circulation
Therefore, researchers should consider using lower doses when administering the peptide subcutaneously for longer periods of time
doi:10.1007/s00203-021-02414-3
In these seven clinical trials, the safety and tolerability of divalproex sodium in pediatric patients were shown to be comparable to those in adults [seeAdverse Reactions (6)]
